Related Experiment Video
Updated: Jul 12, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole
1Dept. of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland. christoph.gubler@spitaluster.ch
Abstract:
We describe a case of cerebral aspergillosis which was successfully treated with a combination of caspofungin and voriconazole. The patient remains in remission 18 months after stopping antifungal treatment. We discuss primary and salvage therapy of invasive aspergillosis with focus on cerebral involvement. Since historical data showed a fatal outcome in most cases, amphotericin B does not cross the blood brain barrier while voriconazole does, we chose a combination of voriconazole plus caspofungin as primary therapy.
Insights
Cerebral aspergillosis, a serious fungal infection, was successfully treated using a combination of caspofungin and voriconazole. This antifungal therapy led to sustained remission in the patient, highlighting a promising treatment approach for invasive aspergillosis.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Neurology
Background:
- Invasive aspergillosis poses a significant threat, particularly when it affects the central nervous system.
- Traditional treatments like amphotericin B have limitations due to poor blood-brain barrier penetration.
- Cerebral aspergillosis historically has a high mortality rate.
Observation:
- A unique case of cerebral aspergillosis was managed using a combined therapeutic strategy.
- The treatment regimen involved the administration of caspofungin and voriconazole.
- The patient achieved a complete remission of the infection.
Findings:
- The combination of caspofungin and voriconazole proved effective in treating cerebral aspergillosis.
- The patient remained disease-free for 18 months post-treatment cessation.
- Voriconazole's ability to cross the blood-brain barrier was crucial for targeting the cerebral infection.
Implications:
- This case supports the use of voriconazole-based combination therapy as a primary treatment for invasive cerebral aspergillosis.
- Salvage therapy options for refractory cases of invasive aspergillosis involving the brain warrant further investigation.
- Successful treatment outcomes can be achieved even in complex neurological fungal infections.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Candidiasis
Fungal Phylum Ascomycota
Brain Abscess l: Introduction
Fungal Phylum Microsporidia